MJA
MJA

A Quality Use of Medicines program for continuity of care in therapeutics from hospital to community

Joseph J Gelb
Med J Aust 2003; 178 (6): .
Published online: 17 March 2003

To the Editor: The article by Mant et al1 and the letters following its publication focus attention on a long-standing problem that, despite concerted efforts by governments, healthcare providers and other stakeholders to address it, remains a major obstacle to effective and appropriate continuity of pharmacotherapy following discharge from hospital.

Online responses are no longer available. Please refer to our instructions for authors page for more information.